期刊文献+

IκBα突变体的真核表达载体构建及表达 被引量:1

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene
在线阅读 下载PDF
导出
摘要 目的:构建NF-κB的抑制蛋白IκBα突变体(IκBαM)的真核表达载体,检测其在内皮细胞中的表达。方法:从克隆质粒pSP64TL-IκBαM中用限制性内切酶双酶切IκBαM cDNA片段,克隆到真核表达质粒pcDNA 3.1/myc-His A内构建pcDNA 3.1/myc-His A-IκBαM质粒,并酶切鉴定及测序分析。以脂质体法转染内皮细胞,观察其表达及活性。结果:pcDNA 3.1/myc-His A-IκBαM质粒含有大小正确的IκBαM cDNA碱基片段,其碱基序列为编码目的基因的正确序列。pcDNA 3.1/myc-His A-IκBαM质粒能在内皮细胞中表达,并抑制IL-6分泌。结论:真核表达质粒pcDNA 3.1/myc-His A-IκBαM构建成功,IκBαM蛋白在内皮细胞中表达,并具有良好的生物学活性。 Objective: To construct eukaryotic expression plasmid of IκBα mutant (IκBαM)gene and to investigate its expression in endothelial cells. Methods:IκBαM cDNA was obtained from plasmids pSP64TL- IκBα M by digestion with Hind Ⅲ and Xba Ⅰ, and cloned into pcDNA 3. 1/myc-His to construct pcDNA 3.1/myc-His - IκBαM eukaryotic expression vector. The sequence of the plasmid was confirmed by restricting enzyme digestion and DNA sequencing. Then the plasmid was transfected into endothelial cells by liposome-mediated gene transfer method,and IκBαM protein and its activity were determined. Results. pcDNA 3. 1/myc-His -IκBαM contained the correct nucleotide sequence of the full length of IκBαM eDNA fragment. The IκBαM eDNA fragment had been inserted into the eukaryotic expression plasmid pcDNA 3.1/myc-His A, and was formed into the pcDNA 3. 1/myc-His A-IκBαM. The IκBαM gene was expressed successfully in the transfected endothelial cells. The level of IL-6 secreted by the transfected cells was decreased. Conclusion: The pcDNA 3.1/myc-His A- IκBαM,an eukaryotic expression plasmid for IκBαM was constructed successfully. The IκBαM gene was expressed successfully in the transfected endothelial cells with good biological activity.
出处 《武汉大学学报(医学版)》 CAS 2006年第1期9-12,共4页 Medical Journal of Wuhan University
基金 武汉大学人才专项基金资助(编号:502273106)
关键词 IκBα突变体 真核表达 基因克隆 内皮细胞 IκBα Mutant Eukaryotic Expression Gene Cloning Endothelial Cells
  • 相关文献

参考文献5

  • 1Heimberg H, Heremans Y, Jobin C, et al. Inhibition of cytokine-induced NF-кB activation by adenovirus-mediated expression of a NF-кB super-repressor prevents β-cell apoptosis[J]. Diabetes,2001,50:2 219.
  • 2Chen F, Castranova V, Shi X, et al. New insights into the role of nuclear factor кB aubiquitous trascription factor in the initiation of diseases[J]. Clin Chem, 1999,45:72.
  • 3Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences[J]. Cell,1986,46:705.
  • 4Chen LF, Greene WC. Shaping the nuclear action of NF-kappa B[J]. Nat Rev Mol Cell Biol,2004, 5:392.
  • 5Jobin C, Panja A, Hellerbrand C, et al. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor кB super-repressor in human intestinal epithelial cells[J]. J Immunol,1998,160: 410.

同被引文献7

  • 1Heimberg H, Heremans Y, Jobin C, et al. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis [J]. Diabetes, 2001, 50 (10): 2219 - 2224.
  • 2Lee C M, Lee R J, Handrahan D L, et al. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors[J]. Urology, 2005,65(1) :114-119.
  • 3Chendil D, Das A, Dey S, et al. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3[J]. Cancer Biol Ther, 2002,1(2) :152-160.
  • 4Raffoul J J, Wang Y, Kucuk O, et al. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest[J], BMC Cancer, 2006,26(6) : 107.
  • 5Warren G, Grimes K, Xu Y, et al. Selectively enhanced radiation sensitivity in prostate cancer cells associated with proteasome inhibitionl[J]. Oncol Rep, 2006,15 ( 5 ) : 1287-1291.
  • 6Sato T, Odagiri H, Ikenaga S K, et al. Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkappaBalpha super-repressor[J]. Cancer Sci, 2003,94 (5) 1467-472.
  • 7Corcoran N M, Costello A J, Hovens C M. Interfering with cell-survival signalling as a treatment strategy for prostate cancer[J]. BJU Int, 2006,97(6) :1149-1153.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部